Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
批准号:
10186454
负责人:
GUANGMING ZHONG
金额:
$11.13万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-13 至 2023-07-31
中文摘要
项目总结/摘要
此T32申请寻求对该大学免疫学研究生研究项目(GRIP)的支持
德克萨斯健康科学中心圣安东尼奥(UT Health SA)。GRIP将培养三名博士,DDS/PhD和MD/PhD
学生每年在学术界,工业界或政府的成功职业生涯。它将研究活动
UT Long医学院基础科学和临床部门/中心,其中包括NCI
指定UT健康MD安德森癌症中心SA,NIH/CTSA-美国国立卫生研究院支持UT健康研究所,
医学和科学的整合(UT IIMS),以及当地的附属德克萨斯生物医学研究所
和UT系统的姐妹机构德克萨斯大学圣安东尼奥(UTSA)。 凭借强大的生物医学研究
存在,一个新兴的生物技术产业和最大的军事生物医学全国集中
活动,圣安东尼奥,南得克萨斯州的自然资本,完成,与达拉斯和休斯顿,得克萨斯州的生物医学
三角 GRIP的所在地将是UT Long医学院。 微生物学、免疫学和
分子遗传学(MIMG),一个学术,科学和行政结构,促进,培养和
整合先天性和适应性免疫、B和T的分子和细胞机制的研究和培训
细胞生物学、抗体基因表达和表观遗传学、衰老免疫学、自身免疫、微生物
发病机理和癌症免疫学。 GRIP将由新的MIMG主席Paolo Casali博士领导,
著名的免疫学家,有成就的研究生教育家和NIH研究生培训计划的前主任
在免疫学上。GRIP依靠32位导师的贡献,其中许多人是各自领域的领导者,
教师和6名教师职业顾问从MIMG和其他部门。它将受益于外部咨询
著名免疫学家委员会。 GRIP学员将从一个多样化的优秀人才库中挑选,
学生在现有的免疫学-免疫学重点博士学位。程序.独特的UT Health SA环境提供
转化研究培训的天然孵化器。 因此,GRIP提供了丰富的培训机会
通过转化科学证书计划,并为每个人提供个性化的发展计划。
培训生,强大的负责任的研究指导行为,全面的进度评估计划和访问
一个强大的职业发展办公室 UT健康SA,教育部-指定的西班牙裔-
服务机构,制定了积极的外展计划,以吸引代表性不足的少数民族学生
(统一登记册)。 URM学员对UT Health SA的成功至关重要,并将成为GRIP不可或缺的一部分。 UT
卫生SA对GRIP的机构承诺是强有力的,为项目主任提供10%的工资支持,
为额外的第四个培训名额提供匹配支持,并为每个学员提供重要的津贴补充支持。
因此,通过利用现有的地方优势,GRIP将提供个性化和多学科的培训,
研究生成为多样化且不断发展的生物医学领域的领导者。
英文摘要
Project Summary/Abstract
This T32 application seeks support for a Graduate Research in Immunology Program (GRIP) at the University
of Texas Health Science Center San Antonio (UT Health SA). GRIP will train three PhD, DDS/PhD and MD/PhD
students per year for successful careers in academia, industry or government. It integrates the research activities
of the UT Long School of Medicine basic science and clinical departments/centers, which includes the NCI-
Designated UT Health MD Anderson Cancer Center SA, the NIH/CTSA-supported UT Health Institute for
Integration of Medicine and Science (UT IIMS), as well as the local affiliate Texas Biomedical Research Institute
and UT System sister institution University of Texas San Antonio (UTSA). With a strong biomedical research
presence, an emerging biotech industry and the greatest countrywide concentration of military biomedical
activities, San Antonio, natural capital of South Texas, completes, with Dallas and Houston, the Texas biomedical
triangle. The home to GRIP will be the UT Long School of Medicine Dept. of Microbiology, Immunology &
Molecular Genetics (MIMG), an academic, scientific and administrative structure promoting, fostering and
integrating research and training in molecular and cell mechanisms of innate and adaptive immunity, B and T
cell biology, antibody gene expression and epigenetics, immunology of aging, autoimmunity, microbial
pathogenesis and cancer immunology. GRIP will be led by the new MIMG chairman, Dr. Paolo Casali, a
renowned immunologist, accomplished graduate educator and former director of NIH graduate training programs
in immunology. GRIP counts on the contribution of 32 preceptors, many of them leaders in their fields, 5 support
faculty and 6 faculty career advisors from MIMG and other departments. It will benefit from an External Advisory
Board of well-known immunologists. GRIP trainees will be selected from a diverse and outstanding pool of
students within an existing Immunology-focused Ph.D. program. The unique UT Health SA environment provides
a natural incubator for translational research training. Thus, GRIP provides enriched training opportunities
through a Translational Sciences Certificate Program, and provides an Individualized Development Plan for each
trainee, strong Responsible Conduct of Research mentoring, a thorough Progress Evaluation Plan and access
to a robust Office of Career Development. UT Health SA, a Department of Education-Designated Hispanic-
Serving Institution, has developed aggressive outreach programs to attract underrepresented minority students
(URMs). URM Trainees have been critical to UT Health SA success and will be an integral part of GRIP. UT
Health SA institutional commitment for GRIP is strong, providing 10% salary support to the Program Director,
matching support for an additional 4th training slot, and significant stipend supplemental support for each trainee.
Thus, by leveraging existing local strengths, GRIP will provide individualized and multidisciplinary training for
graduate students to become leaders in diverse and evolving biomedical fields.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chlamydia pathogenesis
-
批准号:10665396
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2022
-
负责人:GUANGMING ZHONG
-
依托单位:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
-
批准号:10410482
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2018
-
负责人:GUANGMING ZHONG
-
依托单位:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
-
批准号:9757595
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2018
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7760842
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7559682
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Cell Apoptosis
-
批准号:7178453
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7031922
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7339909
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7337131
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8423042
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7538377
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7152929
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8213426
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7037624
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8057006
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8602787
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:6906307
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:6828399
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:GUANGMING ZHONG
-
依托单位:
Novel Chlamydia Vaccine Candidates
-
批准号:6866201
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2004
-
负责人:GUANGMING ZHONG
-
依托单位:
Exacerbation of Atherosclerosis
-
批准号:6750053
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2001
-
负责人:GUANGMING ZHONG
-
依托单位:
海外基金